Include nebulization methodology, nebulizer types: CDSCO Panel Tells Glenmark pharmaceuticals on Pulmonary FDC Dr. Divya Colin14 Jun 2024 6:00 PM ISTNew Delhi: Citing to include nebulization methodology, type of nebulizer, and interface, the Subject Expert Committee (SEC) functional under the...
Zuventus Healthcare gets CDSCO Panel Nod To Manufacture, Market Edoxaban film-coated tablets Dr. Divya Colin13 Jun 2024 6:00 PM ISTNew Delhi: Zuventus Healthcare has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Akums Drugs and Pharmaceuticals Gets CDSCO Panel Nod To study Dapagliflozin plus Bisoprolol FDC Dr. Divya Colin12 Jun 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has granted permission to the...
DCGI Grants registration to Laboratory for testing Medical Devices, in vitro diagnostics on behalf of manufacturer Dr. Divya Colin11 Jun 2024 6:00 PM ISTNew Delhi: In a bold attempt to enhance in vitro diagnostics (IVDs) and medical device quality, safety, and performance, through the recent circular,...
GSK pharma Gets CDSCO Panel Nod To study Respiratory Syncytial Virus vaccine RSVPreF3 OA Dr. Divya Colin10 Jun 2024 6:00 PM ISTNew Delhi: Advising to include clinical trial sites from various states in the southern part of India, the Subject Expert Committee (SEC) functional...
CDSCO asks SLAs to Provide list of antibiotic combinations licensed for manufacturing and marketing Dr. Divya Colin9 Jun 2024 6:00 PM ISTNew Delhi: With an aim to reduce the excessive and irrational use of antibiotics, the Directorate General of Health Services, the Central Drugs...
BDR Pharmaceuticals gets CDSCO panel nod to manufacture, market anticancer drug Abiraterone Acetate Oral Suspension Dr. Divya Colin8 Jun 2024 10:07 PM ISTNew Delhi: In a significant development, BDR Pharmaceuticals has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central...
Conduct Phase III CT: CDSCO panel tells Dr Reddy's Labs after noting Dutasteride linked with AEs like sexual impotence Dr. Divya Colin7 Jun 2024 6:13 PM ISTNew Delhi: Noting that the drug Dutasteride is associated with significant incidence of adverse events including sexual impotence the Subject Expert...
NPPA revises ceiling price of anti Tuberculosis drug Isoniazid Dr. Divya Colin6 Jun 2024 7:58 PM ISTNew Delhi: Through a recent notice, after considering the Wholesale Price Index (WPI) at 0.00551% for the year 2024, the National Pharmaceutical...
Sun Pharma Labs gets CDSCO Panel nod to study synthetic-origin Semaglutide solution for injection Dr. Divya Colin5 Jun 2024 9:11 PM ISTNew Delhi: Responding to the proposal for granting permission to manufacture and market semaglutide solution for injection (synthetic origin), the...
Submit self declaration for FY 2024-2025 under UCPMP by June 30: Department of Pharmaceuticals Susmita Roy4 Jun 2024 3:21 PM ISTNew Delhi: Through a recent notice, the Ministry of Chemicals and Fertilizers, Department of Pharmaceuticals, the Government of India has written to...
Incorporate sample size proportionate with each indication: CDSCO Panel Tells Sun Pharma on Ranibizumab study Dr. Divya Colin3 Jun 2024 6:00 PM ISTNew Delhi: Reviewing the proposal for conducting the Phase IV study of Ranibizumab Solution for Injection 10 mg/mL, the Subject Expert Committee (SEC)...
